LIN · News · 20260907N

End-Market Demand Trends

LINDE PLC · 2026-09-07 · Importance 17 · Surprise 24

UBS expects Linde’s volumes to improve and backlog contributions to support demand through 2027. The commentary identifies Lincare’s healthcare business and helium operations as areas facing challenges. UBS’s outlook follows discussions with Linde’s CFO and investor-relations team, although the report provides no quantified order or backlog data.

Key facts

• Linde's stock was up 12.00% since the start of the year as of September 4, 2026. source
• Linde's stock closed at USD 477.51 on the CBOE on September 4, 2026, marking a 0.93% decline. source
• Linde's stock fell 2.45% over the past five trading sessions as of September 4, 2026. source
• Linde closed at USD 477.51 on September 4, 2026, a 0.93% daily loss noted as positioning it within a normal trading range. source
• Analysts' average target price for Linde is around USD 545.38 and the consensus rating is "Buy" (as reported). source